Search results for: 'Plug Power'

The medical imaging and informatics industry is evolving, with vendors launching new products and solutions every other day. As the reimbursement environment transitions from fee-for-service to value-based payment, vendors business models and value propositions are changing. New evidence on the use of specific imaging techniques is influencing chan...

This Frost & Sullivan study focuses on sustainability in the MedTech industry and offers a detailed discussion on 2 sustainability programs, Climate Action and Responsible Consumption and Production. The study's focus areas include key regulations in the EU, such as the EUDAMED database and green taxonomy and ESG in the United States and Asia-Pacif...

01 Feb 2021  |  North America  |  Market Research

Digital Transformation in Imaging Powering the Next Wave of Growth in Informatics

Future Growth Potential Enhanced by Growth Opportunities in Enterprise Imaging IT

Infographics

×

The global medical imaging and informatics industry is undergoing rapid change with the emergence of new technologies, evolving clinical and administrative needs, and the introduction of new policies and regulations, making it necessary for industry participants to continuously innovate to maintain their competitive edge. New technologies such as A...

As the industry continues its innovation spree across novel small and large molecule therapies, such as RNA targeted small molecules, cell and gene therapies (CGT), and mRNA therapies, it is imperative for pharma sponsors to pursue partnerships to gain technology access, database generation and analysis, and pre-clinical and clinical research. Furt...

Hospitals are under extreme pressure to reduce or cut costs and become more profitable. Operating rooms (ORs) drive approximately 60% of revenue in the average hospital. The most critical hospital issues entail finding new methods to reduce human errors and improve efficiency and quality of surgical care. New technology is now available to help hos...

03 Feb 2021  |  North America  |  Market Research

Companion Diagnostics (CDx) is Revolutionizing the Global Clinical Next-generation Sequencing (NGS) Market

Next-generation Blockchain-Powered Genomic Data Marketplaces are Creating New Growth Opportunities

Infographics

×

2020 will be remembered for the COVID-19 pandemic, masks, social distancing protocol, alternate care sites, Moderna, Pfizer, BioNTech, AstraZeneca, RT-PCR, and serology testing (or all the above). However, in the midst of our response to the global pandemic, remarkable advancements were made in another great frontier in medicine that remains unconq...

12 Aug 2020  |  North America  |  Market Research

New Drug Development for Rare Pediatric Disorders Sustaining High Growth in the Global Orphan Drugs Market, 2019–2025

AI-powered Early Disease Diagnosis and Drug Repurposing will Create New Growth Opportunities

Infographics

×

Key Issues Addressed

Rare diseases have been an increasing area of focus as three waves have converged in recent years: genomic research and innovations becoming mainstream; the forthcoming regulatory policies and financial incentives put in place by the federal agencies; and the increasingly patient-centric and coordinated efforts of patient advocacy groups, caregive...

Smart implants are medical devices that incorporate sensors, electronics, and wireless communication technologies to provide unprecedented diagnostic and therapeutic capabilities. In this report, Frost & Sullivan analyzes smart implants with monitoring capabilities that can track different implant types and provide patient health data to clinicia...

24 Aug 2021  |  North America  |  Market Research

US and EU Biotech Industry VC Investment Growth Opportunities

Future Growth Potential Driven by Next-generation Cell and Gene Platform Technology Powered by AI

Infographics

×

With this research service, Frost & Sullivan provides critical insights into the biotech, and cell and gene therapy (CGT) venture capital (VC) investment trends highlighting the growth opportunities, key countries in the VC environment, and major trends in cell and gene therapy segment. The study also identifies actionable growth opportunities for ...